Characterization of the molecular pharmacology of AMD3100: A specific antagonist of the G-protein coupled chemokine receptor, CXCR4-Reference-Cited by-同舟云学术

Characterization of the molecular pharmacology of AMD3100: A specific antagonist of the G-protein coupled chemokine receptor, CXCR4

Published:2006-08 Issue:5 Volume:72 Page:588-596
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Fricker Simon P.,Anastassov Virginia,Cox Jennifer,Darkes Marilyn C.,Grujic Ognjen,Idzan Stefan R.,Labrecque Jean,Lau Gloria,Mosi Renee M.,Nelson Kim L.,Qin Ling,Santucci Zeffy,Wong Rebecca S.Y.

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference51 articles.

1. A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1);Bleul;J Exp Med,1996

2. Chemokines and leukocyte traffic;Baggiolini;Nature,1998

3. A novel CXC chemokine PBSF/SDF-1 and its receptor CXCR4: their functions in development, hematopoiesis and HIV infection;Nagasawa;Semin Immunol,1998

4. Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1;Nagasawa;Nature,1996

5. Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice;Ma;Proc Natl Acad Sci USA,1998

Cited by 187 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and therapeutic perspectives of CXCR4 antagonists for disease therapy;European Journal of Medicinal Chemistry;2024-09

2. Radiosynthesis and preclinical evaluation of a 68Ga-labeled tetrahydroisoquinoline-based ligand for PET imaging of C-X-C chemokine receptor type 4 in an animal model of glioblastoma;EJNMMI Radiopharmacy and Chemistry;2024-08-20

3. A promising strategy of surface-modified nanoparticles targeting CXCR4 for precision cancer therapy;Journal of Drug Targeting;2024-04-29

4. Biological and mutational analyses of CXCR4–antagonist interactions and design of new antagonistic analogs;Bioscience Reports;2023-12

5. The development of potent, competitive CXCR4 antagonists for the prevention of cancer metastasis;Biochemical Pharmacology;2023-12